Plain-English translation of NCT06198725 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding a high-fiber dietary product to standard insulin treatment can help children with newly diagnosed type 1 diabetes. Researchers believe that changes to gut bacteria through diet might help protect the body's insulin-producing cells and improve blood sugar management. The study will compare children who receive the high-fiber product with those who receive standard diabetes care alone.
When children are first diagnosed with type 1 diabetes, their bodies still produce some insulin on their own—but this ability is fading. This trial exists because researchers want to find ways to slow down or preserve that remaining insulin production early on, which could make blood sugar easier to manage and reduce the amount of insulin children need to inject.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the high-fiber diet group or the standard care group. If assigned to the high-fiber group, you will take a high-fiber dietary product (28 grams of fiber per day) for 12 weeks while continuing your regular insulin injections. Both groups will have their blood sugar, insulin production, and gut bacteria monitored before and after the 12-week period to see if the high-fiber product makes a difference.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China